These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 19593180
1. Venlafaxine metabolism as a marker of cytochrome P450 enzyme 2D6 metabolizer status. Nichols AI, Lobello K, Guico-Pabia CJ, Paul J, Preskorn SH. J Clin Psychopharmacol; 2009 Aug; 29(4):383-6. PubMed ID: 19593180 [Abstract] [Full Text] [Related]
2. Differential outcomes from metabolic ratios in the identification of CYP2D6 phenotypes--focus on venlafaxine and O-desmethylvenlafaxine. Kandasamy M, Srinivas P, Subramaniam K, Ravi S, John J, Shekar R, Srinivas N, Thangam S. Eur J Clin Pharmacol; 2010 Sep; 66(9):879-87. PubMed ID: 20446083 [Abstract] [Full Text] [Related]
6. Influence of CYP2D6 genotype on the disposition of the enantiomers of venlafaxine and its major metabolites in postmortem femoral blood. Kingbäck M, Karlsson L, Zackrisson AL, Carlsson B, Josefsson M, Bengtsson F, Ahlner J, Kugelberg FC. Forensic Sci Int; 2012 Jan 10; 214(1-3):124-34. PubMed ID: 21840145 [Abstract] [Full Text] [Related]
7. Effect of cytochrome P450 enzyme polymorphisms on pharmacokinetics of venlafaxine. McAlpine DE, Biernacka JM, Mrazek DA, O'Kane DJ, Stevens SR, Langman LJ, Courson VL, Bhagia J, Moyer TP. Ther Drug Monit; 2011 Feb 10; 33(1):14-20. PubMed ID: 21099743 [Abstract] [Full Text] [Related]
9. Nifedipine Does Not Alter the Pharmacokinetics of Venlafaxine Enantiomers in Healthy Subjects Phenotyped for CYP2D6, CYP2C19, and CYP3A. Tozatto E, Benzi JRL, Rocha A, Coelho EB, Lanchote VL. J Clin Pharmacol; 2021 Mar 10; 61(3):319-327. PubMed ID: 32974907 [Abstract] [Full Text] [Related]
16. Severe acute cardiomyopathy associated with venlafaxine overdose and possible role of CYP2D6 and CYP2C19 polymorphisms. Vinetti M, Haufroid V, Capron A, Classen JF, Marchandise S, Hantson P. Clin Toxicol (Phila); 2011 Nov 10; 49(9):865-9. PubMed ID: 22077251 [Abstract] [Full Text] [Related]
17. Impact of age on serum concentrations of venlafaxine and escitalopram in different CYP2D6 and CYP2C19 genotype subgroups. Waade RB, Hermann M, Moe HL, Molden E. Eur J Clin Pharmacol; 2014 Aug 10; 70(8):933-40. PubMed ID: 24858822 [Abstract] [Full Text] [Related]
18. Effect of ketoconazole on venlafaxine plasma concentrations in extensive and poor metabolisers of debrisoquine. Lindh JD, Annas A, Meurling L, Dahl ML, AL-Shurbaji A. Eur J Clin Pharmacol; 2003 Sep 10; 59(5-6):401-6. PubMed ID: 12898080 [Abstract] [Full Text] [Related]
19. Effects of CYP2D6 Genotypes on Venlafaxine Metabolism in Japanese Psychiatric Patients With Depression. Komahashi-Sasaki H, Yasui-Furukori N, Sasaki T, Shinozaki M, Hayashi Y, Kato K, Inoue Y, Tsuchimine S, Watanabe T, Sugawara N, Shimoda K. Ther Drug Monit; 2021 Oct 01; 43(5):681-687. PubMed ID: 33306568 [Abstract] [Full Text] [Related]